Monika Elisabeth Bjerke Svanberg
Geen lopende functies
Loopbaan van Monika Elisabeth Bjerke Svanberg
Eerdere bekende functies van Monika Elisabeth Bjerke Svanberg
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Springfondet Management AS
 Springfondet Management AS Investment ManagersFinance Springfondet Management AS (Springfondet) is an independent Norwegian venture capital firm which was established as a joint venture in 2005 by Forskningsparken AS (Oslo Innovation Center) and Kistefos AS. Based in the Oslo Innovation Center in Oslo, Springfondet manages the Springfondet funds, providing entrepreneurial, technology and development expertise to investee companies. | Private Equity Investor | 22-04-2009 | 30-09-2011 |
Lauras AS
 Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Directeur/Bestuurslid | 10-08-2009 | - |
Statistieken
Internationaal
| Noorwegen | 3 |
Operationeel
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectoraal
| Finance | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Springfondet Management AS
Springfondet Management AS Investment ManagersFinance Springfondet Management AS (Springfondet) is an independent Norwegian venture capital firm which was established as a joint venture in 2005 by Forskningsparken AS (Oslo Innovation Center) and Kistefos AS. Based in the Oslo Innovation Center in Oslo, Springfondet manages the Springfondet funds, providing entrepreneurial, technology and development expertise to investee companies. | Finance |
Lauras AS
Lauras AS Miscellaneous Commercial ServicesCommercial Services Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway. | Commercial Services |
